Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-09-19

FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA note of a supplemental application for Nasacort Allergy 24HR (triamcinolone acetonide) by Chattem, Inc., likely supporting labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE)

Snippet

SUPPL AP for NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE)